Overview
Product name | Biotinylated Recombinant Human LAG-3/CD223 Protein |
---|
Catalog No. | RP02553B |
---|
Description | Biotinylated Recombinant Human LAG-3/CD223 Protein is produced by Expi293 expression system. The target protein is expressed with sequence (Leu23-Gly434) of Human LAG-3/CD223 fused with a His and Avi tag at the C-terminal. |
---|
Purity | > 95% by Tris-Bis PAGE;> 95% by SEC-HPLC |
---|
Endotoxin | < 1 EU/μg of the protein by LAL method. |
---|
Formulation | Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.4. |
---|
Species | Human |
---|
Calculated MW | 47.3 kDa |
---|
Background
LAG-3, is a protein which in humans is encoded by the LAG3 gene, which is a cell surface molecule with diverse biologic effects on T cell function. It is an immune checkpoint receptor and as such is the target of various drug development programs by pharmaceutical companies seeking to develop new treatments for cancer and autoimmune disorders.
Product information
Synonym | CD223; FDC; LAG3; LAG-3; sLAG-3 |
---|
Expression Host | HEK293 cells |
---|
Tag | C-His&Avi |
---|
Swiss-Prot | |
---|
Gene ID | |
---|
Usage guide
Storage | Store at -20℃. Store the lyophilized protein at -20℃ to -80℃ up to 1 year from the date of receipt. After reconstitution, the protein solution is stable at -20℃ for 3 months, at 2-8℃ for up to 1 week. |
---|
Reconstitution | Centrifuge the tube before opening. Reconstitute to a concentration of 0.1-0.5 mg/mL in sterile distilled water. Avoid vortex or vigorously pipetting the protein. For long term storage, it is recommended to add a carrier protein or stablizer (e.g. 0.1% BSA, 5% HSA, 10% FBS or 5% Trehalose), and aliquot the reconstituted protein solution to minimize free-thaw cycles. |
---|
* For research use only. Not for therapeutic or diagnostic purposes.